1. Home
  2. TSBX vs PET Comparison

TSBX vs PET Comparison

Compare TSBX & PET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSBX
  • PET
  • Stock Information
  • Founded
  • TSBX 2015
  • PET 2015
  • Country
  • TSBX United States
  • PET United States
  • Employees
  • TSBX N/A
  • PET N/A
  • Industry
  • TSBX
  • PET EDP Services
  • Sector
  • TSBX
  • PET Technology
  • Exchange
  • TSBX Nasdaq
  • PET Nasdaq
  • Market Cap
  • TSBX 10.2M
  • PET 10.7M
  • IPO Year
  • TSBX 2023
  • PET N/A
  • Fundamental
  • Price
  • TSBX $0.43
  • PET $0.26
  • Analyst Decision
  • TSBX Buy
  • PET Strong Buy
  • Analyst Count
  • TSBX 3
  • PET 5
  • Target Price
  • TSBX $4.75
  • PET $4.40
  • AVG Volume (30 Days)
  • TSBX 158.9K
  • PET 841.2K
  • Earning Date
  • TSBX 03-20-2025
  • PET 02-12-2025
  • Dividend Yield
  • TSBX N/A
  • PET N/A
  • EPS Growth
  • TSBX N/A
  • PET N/A
  • EPS
  • TSBX N/A
  • PET N/A
  • Revenue
  • TSBX N/A
  • PET $76,747,000.00
  • Revenue This Year
  • TSBX N/A
  • PET N/A
  • Revenue Next Year
  • TSBX N/A
  • PET $6.78
  • P/E Ratio
  • TSBX N/A
  • PET N/A
  • Revenue Growth
  • TSBX N/A
  • PET N/A
  • 52 Week Low
  • TSBX $0.40
  • PET $0.14
  • 52 Week High
  • TSBX $5.75
  • PET $2.47
  • Technical
  • Relative Strength Index (RSI)
  • TSBX 39.13
  • PET 48.38
  • Support Level
  • TSBX $0.41
  • PET $0.25
  • Resistance Level
  • TSBX $0.62
  • PET $0.27
  • Average True Range (ATR)
  • TSBX 0.06
  • PET 0.03
  • MACD
  • TSBX -0.01
  • PET 0.00
  • Stochastic Oscillator
  • TSBX 8.96
  • PET 32.50

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

About PET Wag! Group Co.

Wag Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent Pet Caregivers to connect with pet parents. The platform allows pet parents to make pet service requests in the platform, which can then be fulfilled by Pet Caregivers. Wag supports dog walking, pet sitting, pet boarding, drop-in visits at the pet parent's home, advice from licensed pet experts, training services, pet insurance comparison tools, and pet wellness plans.

Share on Social Networks: